Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jensen-Salsbery Laboratories, commonly known as Jen-Sal, was a pioneering American veterinary pharmaceutical and biologicals company founded in 1913 by Dr. Hans Jensen and Dr. C.E. Salsbery. Based in Kansas City, Missouri, the firm specialized in the development and manufacture of vaccines, serums, and pharmaceutical products specifically for the veterinary profession. The company was a leader in animal health for several decades, notably contributing to the control of rabies and various livestock diseases through its innovative biological products. In 1955, Jen-Sal was acquired by Richardson-Merrell, and it later passed through the ownership of Burroughs Wellcome in 1979. Its legacy continues today through the various animal health entities that absorbed its product lines and research, including Merck Animal Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jensen-Salsbery Laboratories.